Back
US Treasury 3 Year Note ETF Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
43
UTRE
US Treasury 3 Year Note ETF
Last Price:
49.16
Seasonality Move:
-0.39%
Sell
1
AGIO
Agios Pharmaceuticals
Last Price:
38.94
Seasonality Move:
12.89%
Sell
43
US Treasury 3 Year Note ETF (UTRE)
is a Sell
Is US Treasury 3 Year Note ETF a Buy, Sell or Hold?
- The current US Treasury 3 Year Note ETF [UTRE] share price is $49.07. The Score for UTRE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- UTRE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $38.17. The Score for AGIO is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
UTRE Stock Price Chart
What is US Treasury 3 Year Note ETF's stock price today?
-
The US Treasury 3 Year Note ETF share price today is $49.07
The current trend is relatively stagnant and UTRE is experiencing selling pressure, which indicates risk of future bearish movement.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $38.17
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
UTRE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.14 | Sell |
| Chaikin Money Flow: | -6744 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (48.95 - 49.13) | Buy |
| Bollinger Bands (100): | (49.09 - 49.81) | Sell |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.34 | Sell |
| Relative Strength Index (14 RSI): | 26.34 | Sell |
| Chaikin Money Flow: | -1550643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (49.73 - 60.93) | Sell |
| Bollinger Bands (100): | (42.01 - 53.19) | Sell |
UTRE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.11 | Sell |
| 20-day SMA: | 49.05 | Buy |
| 50-day SMA: | 49.18 | Sell |
| 200-day SMA: | 49.09 | Sell |
| 8-day EMA: | 49.11 | Sell |
| 20-day EMA: | 49.1 | Sell |
| 50-day EMA: | 49.2 | Sell |
| 200-day EMA: | 49.2 | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 51.89 | Sell |
| 20-day SMA: | 54.55 | Sell |
| 50-day SMA: | 49.66 | Sell |
| 200-day SMA: | 41.9 | Sell |
| 8-day EMA: | 48.9 | Sell |
| 20-day EMA: | 52.35 | Sell |
| 50-day EMA: | 50.92 | Sell |
| 200-day EMA: | 42.82 | Sell |
US Treasury 3 Year Note ETF Earnings Growth & UTRE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
US Treasury 3 Year Note ETF Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||